Transformation of vitamin B6 to (+)-deoxypyridinoline, a useful biochemical marker for diagnosis of bone diseases

Tetrahedron

Volumn 56, Issue 16, 2000, Pages 2379-2390

  Adamczyk, Maciej ^a   Akireddy, Srinivasa Rao ^a   Reddy, Rajarathnam E ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Bone collagen; Cross links; Deoxypyridinoline; Osteoporosis; Poly amino acids

Indexed keywords

COLLAGEN; DEOXYPYRIDINOLINE; IODIDE; PYRIDOXINE; REAGENT;

ARTICLE; BONE DISEASE; CROSS LINKING; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG STRUCTURE; DRUG TRANSFORMATION; METABOLIC BONE DISEASE; OSTEOPOROSIS; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0343619410     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(00)00121-6     Document Type: Article

References (46)

1. For comprehensive study on physiology and pathology of bones see Principles of Bone Biology; Bilezikan, J. P.; Raicz, L. G.; Rogan, G., Eds.; Academic Press: New York, 1996.
2. Fujimoto D., Moriguchi T., Ishida T., Hayashi H. Biochem. Biophys. Res. Commun. 84:1978;52.
3. Ogawa T., Ono T., Tsuda M., Kawanishi Y. Biochem. Biophys. Res. Commun. 107:1982;1252.
4. (a) Watts, N. B. Clin. Chem. 1999, 45, 1359.
5. (b) Knott, L.; Baily, A. J. Bone 1998, 22, 181.
6. (c) James, I. T.; Walne, A. J.; Perrett, D. Ann. Clin. Biochem. 1996, 33, 397.
7. (d) Eyre, D. R. In Principles of Bone Biology; Bilezikan, J. P.; Raicz, L. G.; Rogan, G., Eds.; Academic Press: New York, 1996; p. 143.
8. (a) Eyre, D. R.; Oguchi, H. Biochem. Biophys. Res. Commun. 1980, 92, 403.
9. (b) Robins, S. P. Biochem. J. 1983, 215, 167.
10. (c) Gunja-Smith, Z.; Boucek, R. J. Biochem. J. 1981, 197, 759.
11. (d) Hanson, D. A.; Eyre, D. R. J. Biol. Chem. 1996, 271, 26508.
12. (a) Gomez, Jr., B.; Ardakani, S.; Evans, B. J.; Merrell, L. D.; Jenkins, D. K.; Kung, V. T. Clin. Chem. 1996, 42, 1168.
13. (b) Rosano, T. G.; Peaston, R. T.; Bone, H. G.; Woitge, H. W.; Francis, R. M.; Seibel, M. J. Clin. Chem. 1998, 44, 2126.
14. (c) Sarno, M.; Powell, H.; Tjersland, G.; Schoendorfer, D.; Harris, H.; Adams, K.; Ogata, P.; Warnick, G. R. Clin. Chem. 1999, 45, 1501.
15. (a) Luftner, D.; Gunther, S.; Flath, B.; Muller, C.; Echteroff, K.; Mergenthaler, H.-G.; Wernecke, K.-D.; Possinger, K. Anticancer Res. 1999, 19, 2537.
16. (b) Engler, H.; Koeberle, D.; Thuerlimann, B.; Senn, H.-J.; Riesen, W. F. Clin. Chem. Lab. Med. 1998, 36, 879.
17. (c) Withold, W.; Friedrich, W.; Reinauer, H. Ann. Clin. Biochem. 1996, 33, 421.
18. (d) Westerhuis, L. W.; Delaere, K. P. Eur. J. Clin. Chem. Clin. Biochem. 1997, 35, 89.
19. (a) Delmas, P. D.; Gineyts, E.; Bertholin, A.; Garnero, P.; Marchand, F. J. Bone Miner. Res. 1993, 8, 643.
20. (b) Robins, S. P.; Black, D.; Peterson, C. R.; Reid, D. M.; Duncan, A.; Seibel, M. J. Eur. J. Clin. Clin. Invest. 1991, 21, 310.
21. (c) Body, J. J.; Delmas, P. D. J. Clin. Endocrinol. Metab. 1992, 74, 471.
22. (a) Hoshi, H.; Kushida, K.; Takahashi, M.; Denda, M.; Yamazaki, K.; Yamanashi, A.; Inoue, T. Miner Electrolyte Metab. 1997, 23, 93.
23. (b) Seibel M. J.; Gartenberg, F.; Silverberg, S. J.; Ratcliffee, A.; Robins, S. P.; Bilezikian, J. P. J. Clin. Endocrinol. Metab. 1992, 74, 481.
24. (c) Alvarez, L.; Peris, P.; Guanabens, N.; Herranz, R.; Monegal, A.; Bedini, J. L. Arthritis Rheum. 1997, 40, 461.
25. (a) Arbault, P.; Gineyts, E.; Grimaux, M.; Seguin, P.; Delmas, P. D. J. Liquid Chromatography 1994, 17, 1981.
26. (b) Meddah, B.; Kamel, S.; Giroud, C.; Brazier, M. Prep. Biochem. Biotechnol. 1999, 29, 63.
27. (c) Robins, S. P.; Duncan, A.; Wilson, N.; Evans, B. J. Clin. Chem. 1996, 42, 1621.
28. Waelchli R., Beerli Ch., Meigel H., Revesz L. Bioorg. Med. Chem. Lett. 7:1997;2831.
29. (a) Adamczyk, M.; Johnson, D. D.; Reddy, R. E. Tetrahedron 1999, 55, 63.
30. (b) Adamczyk, M.; Johnson, D. D.; Reddy, R. E. Tetrahedron: Asymmetry 1999, 10, 775.
31. Hatch, R. P. US Patent 5723619, 1998. CA: 1998, 128, 205137.
32. (a) Allevi, P.; Longo, A.; Anastasia, M. Chem Commun. 1999, 559.
33. (b) Allevi, P.; Longo, A.; Anastasia, M. J. Chem. Soc., Perkin Trans 1 1999, 2867.
34. For preliminary results of the work see, Adamczyk, M.; Akireddy, S. R.; Reddy, R. E. Tetrahedron: Asymmetry 1999, 10, 3107.
35. Schollkopf U., Groth U., Deng C. Angew. Chem., Int. Ed. Engl. 20:1981;798.
36. Sibi M.P., Renhowe P.A. Tetrahedron Lett. 31:1990;7407.
37. Korytnyk W., Srivastava S.C., Angelino N., Potti P.G.G., Paul B. J. Med. Chem. 16:1973;1096.
38. (a) Korytnyk, W.; Paul, B. J. Med. Chem. 1970, 13, 187.
39. (b) Williams, K.; Halpern, B. Synthesis 1974, 727.
40. (c) Wuest, H. M.; Bigot, J. A.; DeBoer, T. J.; Wibaut, J. P. Proc. K. Ned. Akad. Wet. Ser. B 1958, 61, 150.
41. The diastereomeric mixture of (S, R/R, R)-17d was incorrectly [(S, R/S, S)] entered in Ref. 15.
42. Davis F.A., Szewczyk J.M., Reddy R.E. J. Org. Chem. 61:1996;2222.
43. Wild D. The Immunoassay Handbook. 1994;Stockton Press, New York.
44. Ishizuka T., Kunieda T. Tetrahedron Lett. 28:1987;4185.
45. Rossi F., Powers E.T., Yoon R., Rosenberg L., Meinwald J. Tetrahedron. 52:1996;10279.
46. Hasimoto N., Aoyama T., Shioiri T. Chem. Pharm. Bull. 29:1981;3249.